Frequently asked clinical questions about medical abortion : conclusions of an International Consensus | Conference on Medical Abortion in early first trimestre, Bellagio, Italy (Record no. 24063)

000 -CABECERA
campo de control de longitud fija 04106nam a22005537a 4500
008 - LONGITUD FIJA
campo de control de longitud fija 140202b ck ||||| |||| 00| 0 spa d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 92 4 159484 5 -- 978 92 4 159484 4
110 1# - AUTOR CORPORATIVO
nombre WHO - World Health Organization
9 (RLIN) 94155
245 10 - TÍTULO PROPIAMENTE DICHO
título Frequently asked clinical questions about medical abortion : conclusions of an International Consensus
245 10 - TÍTULO PROPIAMENTE DICHO
título Conference on Medical Abortion in early first trimestre, Bellagio, Italy
264 ## - PIE DE IMPRENTA
lugar (ciudad) [Geneva] : World Health Organization, 2006
300 ## - DESCRIPCIÓN FÍSICA
Extensión 35 p. ; 21 x 15 cm.
505 00 - NOTA DE CONTENIDO
Nota de contenido Pre-abortion care -- What couynselling is needed by a woman with an unwanted pregnancy who is contemplating
505 00 - NOTA DE CONTENIDO
Nota de contenido abortion? -- What factors should be taken into account when counselling a woman about her choice between
505 00 - NOTA DE CONTENIDO
Nota de contenido medical and surgical abortion? -- What are the contraindications to medical abortion? -- Do any other
505 00 - NOTA DE CONTENIDO
Nota de contenido characteristics of the woman need to be taken into account in providing medical abortion? -- How should
505 00 - NOTA DE CONTENIDO
Nota de contenido pregnancy be confirmed ant gestation estimated? -- What clinical assessment an laboratory investigations are
505 00 - NOTA DE CONTENIDO
Nota de contenido required prior to medical abortion? -- What steps are necessary to minimize the risk of undiagnosed ectopic
505 00 - NOTA DE CONTENIDO
Nota de contenido pregnancy? -- Regimen for medical abortion -- What is the recommended regimen for medical abortion? -- Are
505 00 - NOTA DE CONTENIDO
Nota de contenido other doses of mifepristone possible? -- Are other doses or routes of administration of the prostaglandin
505 00 - NOTA DE CONTENIDO
Nota de contenido possible? -- What are the advantages and disadvantages of misoprostol versus gemeprost? -- Can other
505 00 - NOTA DE CONTENIDO
Nota de contenido prostaglandins be used? -- Is the interval between administration of mifepristone and prostaglandin crucial?
505 00 - NOTA DE CONTENIDO
Nota de contenido -- Can abortion Be Induced using prostaglandin alone? -- What pain relief should Be available to women during
505 00 - NOTA DE CONTENIDO
Nota de contenido medical abortion? -- Postabortion care -- If a woman has an incomplete abortion, is it necessary to evacuate
505 00 - NOTA DE CONTENIDO
Nota de contenido the uterus surgically? -- How should pelvic infection be diagnosed and treated after abortion? -- How should
505 00 - NOTA DE CONTENIDO
Nota de contenido the success of medical abortion be confirmed? -- How should ectopic pregnancy be identified after medical
505 00 - NOTA DE CONTENIDO
Nota de contenido abortion? -- Is there a risk of fetal anormality after an unsuccessful medical abortion? -- Which methodos of
505 00 - NOTA DE CONTENIDO
Nota de contenido contraception can a woman use after medical abortion? -- Issues related to provision of medical abortion
505 00 - NOTA DE CONTENIDO
Nota de contenido services -- Legal and regulatory issues -- Setting up a medical abortion service -- Obtaining the necessary
505 00 - NOTA DE CONTENIDO
Nota de contenido medicines -- Annex --
520 ## - RESUMEN
Resumen On 1-5 November 2004, in Bellagio, Italy, the UNDP/UNFPA/WHO/World Bank Special Programme of Research,
520 ## - RESUMEN
Resumen Development and Research Training in Human Reproduction (HRP), organized a meeting entitled International
520 ## - RESUMEN
Resumen Consensus Conference on Non-surgical (Medical) Abortion in Early First Trimester on Issues Related to Regimens
520 ## - RESUMEN
Resumen and Service Delivery (Annex 1). This document is the result of the deliberations of the participants in that
520 ## - RESUMEN
Resumen meeting, who included highly experienced researchers and clinicians in the area of medical
520 ## - RESUMEN
Resumen abortion.--Background.
530 ## - NOTA DE FORMATO FÍSICO ADICIONAL DISPONIBLE
Nota de formato físico adicional disponible http://whqlibdoc.who.int/publications/2006/9241594845_eng.pdf (File size : 198 KB)
710 1# - COAUTOR CORPORATIVO
Nombre de entidad corporativa o nombre de jurisdicción como elemento de entrada UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human
9 (RLIN) 93782
710 1# - COAUTOR CORPORATIVO
Nombre de entidad corporativa o nombre de jurisdicción como elemento de entrada Reproduction
9 (RLIN) 93616
710 1# - COAUTOR CORPORATIVO
Nombre de entidad corporativa o nombre de jurisdicción como elemento de entrada OMS - Organización Mundial de la Salud
9 (RLIN) 93453
711 ## - COAUTOR DE CONGRESO
Nombre de congreso/reunión o jurisdicción como elemento de entrada International Consensus Conference on Non-surgical (Medical) Abortion in Early First Trimester on Issues
9 (RLIN) 94322
711 ## - COAUTOR DE CONGRESO
Nombre de congreso/reunión o jurisdicción como elemento de entrada Related to Regimens and Service Delivery (2004 : Bellagio, Italy)
9 (RLIN) 94363
082 04 - CLASIFICACIÓN DECIMAL DEWEY
Clasificación 618.88 / W551f
650 14 - MATERIA GENERAL
Término de materia o nombre geográfico como elemento inicial Aborto inducido
Subdivisión general métodos
9 (RLIN) 99081
650 14 - MATERIA GENERAL
Término de materia o nombre geográfico como elemento inicial Agentes abortivos
9 (RLIN) 99698
650 14 - MATERIA GENERAL
Término de materia o nombre geográfico como elemento inicial Servicios de la planificación familiar
9 (RLIN) 131422
650 14 - MATERIA GENERAL
Término de materia o nombre geográfico como elemento inicial Planificación familiar y reproducción humana
9 (RLIN) 127715
650 14 - MATERIA GENERAL
Término de materia o nombre geográfico como elemento inicial Salud
9 (RLIN) 130891

No items available.

Powered by Koha